BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17118960)

  • 1. Azaspiracid-1 alters the E-cadherin pool in epithelial cells.
    Ronzitti G; Hess P; Rehmann N; Rossini GP
    Toxicol Sci; 2007 Feb; 95(2):427-35. PubMed ID: 17118960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective disruption of the E-cadherin-catenin system by an algal toxin.
    Ronzitti G; Callegari F; Malaguti C; Rossini GP
    Br J Cancer; 2004 Mar; 90(5):1100-7. PubMed ID: 14997213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azaspiracid-1 inhibits endocytosis of plasma membrane proteins in epithelial cells.
    Bellocci M; Sala GL; Callegari F; Rossini GP
    Toxicol Sci; 2010 Sep; 117(1):109-21. PubMed ID: 20547569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of yessotoxin stabilizes E-cadherin in mouse colon.
    Callegari F; Sosa S; Ferrari S; Soranzo MR; Pierotti S; Yasumoto T; Tubaro A; Rossini GP
    Toxicology; 2006 Oct; 227(1-2):145-55. PubMed ID: 16950554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yessotoxin inhibits the complete degradation of E-cadherin.
    Callegari F; Rossini GP
    Toxicology; 2008 Feb; 244(2-3):133-44. PubMed ID: 18155346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azaspiracid-1 inhibits the maturation of cathepsin D in mammalian cells.
    Sala GL; Bellocci M; Callegari F; Rossini GP
    Chem Res Toxicol; 2013 Mar; 26(3):444-55. PubMed ID: 23387425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Effects of Lipophilic Phycotoxins (Okadaic Acid, Azapsiracid-1 and Yessotoxin) on Human Intestinal Cells Models.
    Ferron PJ; Dumazeau K; Beaulieu JF; Le Hégarat L; Fessard V
    Toxins (Basel); 2016 Feb; 8(2):50. PubMed ID: 26907345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report on azaspiracid and yessotoxin groups detection in French shellfish.
    Amzil Z; Sibat M; Royer F; Savar V
    Toxicon; 2008 Jul; 52(1):39-48. PubMed ID: 18573273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cardiomyocyte response to YTX- and AZA-1-induced damage: autophagy versus apoptosis.
    Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Santamarina G; Cantalapiedra AG; Cifuentes JM; Crespo A; Botana LM
    Arch Toxicol; 2017 Apr; 91(4):1859-1870. PubMed ID: 27709272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible cytoskeletal disarrangement is independent of caspase activation during in vitro azaspiracid toxicity in human neuroblastoma cells.
    Vilariño N; Nicolaou KC; Frederick MO; Vieytes MR; Botana LM
    Biochem Pharmacol; 2007 Jul; 74(2):327-35. PubMed ID: 17485074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yessotoxin induces the accumulation of altered E-cadherin dimers that are not part of adhesive structures in intact cells.
    Ronzitti G; Rossini GP
    Toxicology; 2008 Feb; 244(2-3):145-56. PubMed ID: 18155345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine toxins and the cytoskeleton: azaspiracids.
    Vilariño N
    FEBS J; 2008 Dec; 275(24):6075-81. PubMed ID: 19016861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell growth inhibition and actin cytoskeleton disorganization induced by azaspiracid-1 structure-activity studies.
    Vilariño N; Nicolaou KC; Frederick MO; Cagide E; Ares IR; Louzao MC; Vieytes MR; Botana LM
    Chem Res Toxicol; 2006 Nov; 19(11):1459-66. PubMed ID: 17112233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of yessotoxins in cultured cells.
    Ferrari S; Ciminiello P; Dell'Aversano C; Forino M; Malaguti C; Tubaro A; Poletti R; Yasumoto T; Fattorusso E; Rossini GP
    Chem Res Toxicol; 2004 Sep; 17(9):1251-7. PubMed ID: 15377159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic and cytoskeletal effects of azaspiracid-1 on mammalian cell lines.
    Twiner MJ; Hess P; Dechraoui MY; McMahon T; Samons MS; Satake M; Yasumoto T; Ramsdell JS; Doucette GJ
    Toxicon; 2005 Jun; 45(7):891-900. PubMed ID: 15904684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic effects of azaspiracid-1 identified by microinjection of Japanese medaka (Oryzias latipes) embryos.
    Colman JR; Twiner MJ; Hess P; McMahon T; Satake M; Yasumoto T; Doucette GJ; Ramsdell JS
    Toxicon; 2005 Jun; 45(7):881-90. PubMed ID: 15904683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of the marine algal toxins azaspiracid-1, -2, and -3 on Jurkat T lymphocyte cells.
    Twiner MJ; El-Ladki R; Kilcoyne J; Doucette GJ
    Chem Res Toxicol; 2012 Mar; 25(3):747-54. PubMed ID: 22375692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional assay to measure yessotoxins in contaminated mussel samples.
    Pierotti S; Malaguti C; Milandri A; Poletti R; Paolo Rossini G
    Anal Biochem; 2003 Jan; 312(2):208-16. PubMed ID: 12531207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined oral toxicity of azaspiracid-1 and yessotoxin in female NMRI mice.
    Aasen JA; Espenes A; Miles CO; Samdal IA; Hess P; Aune T
    Toxicon; 2011 May; 57(6):909-17. PubMed ID: 21426911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azaspiracid substituent at C1 is relevant to in vitro toxicity.
    Vilariño N; Nicolaou KC; Frederick MO; Cagide E; Alfonso C; Alonso E; Vieytes MR; Botana LM
    Chem Res Toxicol; 2008 Sep; 21(9):1823-31. PubMed ID: 18707138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.